Klaria Pharma Announces New SEK 50 Million Financing Agreement
Uppsala, June 18, 2021— Klaria Pharma AB (NASDAQ FIRST NORTH: KLAR), today announced a financing agreement with a consortium lead by Modelio Equity. The financing agreement provides for a loan of up to SEK 50.0 million. SEK 30.0 million will be provided upon closing of the agreement and an additional SEK 20.0 is million available for Klaria to draw down at any time and at Klaria’s option.“We are pleased to announce this new financing with Modelio Equity and the other investors in the consortium,” noted Jesper Wiklund, CEO of Klaria. “We have been in a good financial position in 2021, due